PROPHASE LABS INC. - COMMON STOCK
5.0300
17-5月-24 15:59:53
15 分の遅延
株式
-0.0800
-1.57%
本日の幅
4.9100 - 5.0800
ISIN
N/A
ソース
NASDAQ
-
04 5 2023 08:30:01 提供 Nasdaq GlobeNewswire
-
28 4 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Launch of Redesigned Corporate Website
25 4 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
18 4 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
28 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
21 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces New $6 Million Stock Repurchase Program
15 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test
13 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
07 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
01 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC)
22 2 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
16 2 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
15 2 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
06 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
05 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
19 12 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
30 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
10 11 2022 08:00:04 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
08 11 2022 08:00:01 提供 Nasdaq GlobeNewswire